Extracellular Vesicles in Migraine: Biomarkers and Therapeutics
Abstract
The diagnosis and therapeutic evaluation of migraine have long relied on subjective clinical descriptions, lacking objective, stable, and quantifiable biological markers. Extracellular vesicles (EVs), which carry specific bioactive molecules, have been recognized in recent years as a potential breakthrough in research due to their role in intercellular communication, the stability of their contents, and their reflection of pathological states. This article comprehensively evaluates studies on changes in EVs and their contents in migraine patients, discusses methods for isolating and characterizing EVs, sample sources, and other issues, and critically analyzes existing evidence regarding EVs as biomarkers and therapeutic carriers for migraine. Current research suggests alterations in miRNA and protein profiles in EVs of migraine patients, but these findings generally face reproducibility issues. Finally, the article also elaborates on the numerous challenges encountered during clinical translation. Overall, EVs provide a promising yet immature new perspective for migraine research.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.